Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
01/1998
01/20/1998US5710146 Antibiotics for bactericides
01/20/1998US5710145 Protein kinase C inhibitor
01/20/1998US5710130 Heterocyclic synthetic peptides
01/20/1998US5710116 Color-safe bleach boosters, compositions and laundry methods employing same
01/15/1998WO1998001571A2 Erythromycins and process for their preparation
01/15/1998WO1998001546A2 Polyketides and their synthesis
01/15/1998CA2259463A1 Polyketides and their synthesis
01/14/1998EP0817787A1 Nitrogenous macrocyclic compounds
01/14/1998EP0817635A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
01/14/1998CN1036995C Imidazodiazepine, and its preparation and use
01/13/1998US5708170 Arthropodicidal carboxanilides
01/13/1998US5708123 For use in devices with an electrochromic display or another electrochromic color change or in batteries
01/13/1998US5708002 Ascomycin analogs, immunosuppressants
01/13/1998US5707990 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
01/13/1998US5707988 Anxiolytic agents, cognition activators
01/07/1998EP0816348A1 Heterocyclic n-acetonylbenzamides and their use as fungicides
01/07/1998CN1036920C Heterocycle-containing carbonic acid derivatives
01/06/1998US5705890 Platelet aggregation inhibitor, antithrombotic
01/06/1998US5705703 Enzyme inhibitors of transferases
01/06/1998US5705639 Process to prepare herbicidal bicyclic triazoles
01/06/1998US5705498 Piperidine derivatives as 5-HT4 receptor antagonists
01/06/1998CA2002917C Fluorescent indicator dyes for alkali metal cations
12/1997
12/31/1997WO1997049709A1 Androgen receptor modulator compounds and methods
12/31/1997WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
12/31/1997CN1036849C Method for prepn. of anti-viral compounds
12/30/1997US5703215 Water-soluble dyes which are polymerizable containing molecules which contain a nucleophilic group and an electrophilic group
12/30/1997US5703069 Method for inhibiting and controlling viral growth
12/29/1997EP0813535A1 Hexacyclic camptothecin analogues, and process for preparing them
12/28/1997CA2207951A1 Heterocyclic n-acetonylbenzamides
12/24/1997WO1997048708A1 Dendroamide compounds and their use in chemosensitizing multidrug resistant cells
12/24/1997WO1997048707A1 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
12/24/1997WO1997048705A1 Potassium channel blockers
12/24/1997WO1997048398A1 Liposome preparations of indolocarbazole derivatives
12/24/1997CN1168374A Process for manufacture of azepines of general formula
12/23/1997US5700823 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide or n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide
12/23/1997US5700822 Treatment of platelet derived growth factor related disorders such as cancers
12/18/1997WO1997047626A1 Bicyclic hydantoin derivatives, intermediates for the preparation thereof, process for the preparation of them, and herbicides containing the same as active ingredient
12/18/1997WO1997047625A1 Tricyclic benzazepine vasopressin antagonists
12/18/1997WO1997047301A1 Improved process for preparing potassium clavulanate
12/18/1997WO1997047298A1 Therapeutic treatment for cardiovascular diseases
12/18/1997CA2257693A1 Therapeutic treatment for cardiovascular diseases
12/17/1997EP0812838A1 Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
12/17/1997EP0698025B1 Ampa antagonists and a method of treatment therewith
12/17/1997EP0541807B1 Novel benzopyran derivative
12/17/1997EP0526543B1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
12/16/1997US5698691 Condensed cyclic compounds and their use
12/16/1997US5698675 Reagents for peptide couplings
12/16/1997US5698578 Protein kinase C inhibitors
12/16/1997US5698568 Substance p antagonists
12/16/1997US5698567 Heterocyclic spiro compounds
12/16/1997US5698547 Cephalosporin antibiotics
12/16/1997CA2111446C Chiral intermediates for the preparation of antidiabetics thiazoles
12/11/1997WO1997046565A1 SELECTED DERIVATIVES OF K-252a
12/09/1997US5696258 Reducing to leuco form; reoxidation
12/09/1997US5696129 5-HT4 antagonists
12/09/1997US5696117 Benzoxazine antimicrobial agents
12/09/1997US5696108 Protein kinase C inhibitors
12/03/1997CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997CN1036592C Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/03/1997CN1036591C Carbamates of repamycin
12/03/1997CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/02/1997US5693643 Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
12/02/1997US5693641 Enzyme inhibitor treating blood disorder
12/02/1997US5693635 Tricyclic benzazepine vasopressin antagonists
11/1997
11/27/1997WO1997044040A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
11/26/1997EP0808313A1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
11/25/1997US5690906 Dopamine D-3 and serotonin (5-HT1A) receptor ligands and imaging agents
11/19/1997EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/18/1997US5688950 Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
11/18/1997US5688942 Process for preparing 2-isocephem derivatives
11/18/1997US5688933 Preparation of biologically active compounds from substantially pure enantiomers of 2-azabicyclo 2.2.1!hept-5-en-one
11/18/1997US5688815 Hydroxypyridinones
11/18/1997US5688803 Tricyclic dicarbonyl derivatives
11/18/1997US5688791 Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent
11/18/1997US5688786 β-lactam antibiotics
11/12/1997EP0806426A1 Process for the preparation of clavulanic acid
11/12/1997EP0805812A1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists
11/12/1997EP0600026B1 Cardiac output probe assembly
11/11/1997US5686457 Pyrrolopyrimidine derivatives having pharmacological activity
11/11/1997US5686445 Pyridobenzoxazepine and pyridobenzothiazepine vasopressin antagonists
11/11/1997US5686444 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/11/1997US5686434 3-aryl-2-isoxazolines as antiinflammatory agents
11/06/1997WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997WO1997040831A1 Therapeutic treatment for vegf related occular diseases
11/05/1997EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997EP0804561A1 Regulated transcription of targeted genes and other biological events
11/05/1997EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
11/05/1997EP0804420A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997EP0804191A1 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
11/05/1997EP0804186A1 Indole diterpene alkaloid compounds
11/04/1997US5684003 Gastrointestinal disorders or antiulcer agents
10/1997
10/30/1997WO1997040015A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997CA2251989A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/29/1997EP0802917A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
10/29/1997EP0802913A1 IMIDAZO 4,5-c]QUINOLINE AMINES
10/29/1997CN1163604A Substituted r-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
10/23/1997WO1997039001A1 Isoxazolidine derivatives
10/23/1997WO1997038705A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997CA2251394A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors